ArticleDiscover oncology2022

Validation study of a nomogram for predicting probability of low risk of MammaPrint results in women with clinically high-risk breast cancer.

Young Sol Hwang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.